◆英語タイトル:Cochlear Ltd (COH) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME4946PD
◆発行会社(調査会社):
GlobalData
◆発行日:2021年1月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone anchored prosthetics and wireless accessories including wireless mini microphone, wireless phone clip and wireless TV streamer. It has manufacturing facilities and regional distribution centers in North America and Europe. The company conducts its operations in the Americas, Asia-Pacific, the Middle East and Europe. The company markets its products through subsidiaries, local offices, distributors and agents. Cochlear is headquartered in Sydney, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cochlear Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Cochlear Ltd Company Overview
Cochlear Ltd Company Snapshot
Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
Cochlear Ltd – Pipeline Analysis Overview
Business Description
Cochlear Ltd – Key Facts
Cochlear Ltd – Major Products and Services
Cochlear Ltd Pipeline Products by Development Stage
Cochlear Ltd Ongoing Clinical Trials by Trial Status
Cochlear Ltd Pipeline Products Overview
Custom Sound Pro Fitting Software
Custom Sound Pro Fitting Software Product Overview
Nucleus 7 Sound Processor For Nucleus 22 Implant
Nucleus 7 Sound Processor For Nucleus 22 Implant Product Overview
Nucleus Kanso 2 Sound Processor
Nucleus Kanso 2 Sound Processor Product Overview
Nucleus Profile Plus
Nucleus Profile Plus Product Overview
Nucleus SmartNav System
Nucleus SmartNav System Product Overview
OSIA 2 System
OSIA 2 System Product Overview
OSIA 2 System Clinical Trial
Cochlear Ltd – Key Competitors
Cochlear Ltd – Key Employees
Cochlear Ltd – Key Employee Biographies
Cochlear Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Cochlear Ltd, Recent Developments
May 19, 2020: Cochlear: Denial of appeal rehearing in US patent infringement case
Dec 12, 2019: Cochlear obtains FDA approval for bone conduction implant
Dec 11, 2019: FDA clears Cochlear’s innovative new Osia 2 hearing implant system
Dec 10, 2019: Appointment of Michael Daniell to the Cochlear Limited Board
Nov 18, 2019: Cochlear advises of FDA clearance for the Cochlear Osia 2 System
Oct 02, 2019: Couple discusses impact hearing loss had on relationship
Jun 18, 2019: FDA approves Cochlear Nucleus Profile Plus Series implant
Jun 17, 2019: Cochlear advises of FDA approval for Nucleus Profile Plus Series implant
Jun 03, 2019: How hearing implants for the elderly can improve quality of life
Apr 16, 2019: Cochlear announces the launch of the Nucleus Profile Plus Series implant
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
Cochlear Ltd Pipeline Products by Equipment Type
Cochlear Ltd Pipeline Products by Indication
Cochlear Ltd Ongoing Clinical Trials by Trial Status
Cochlear Ltd, Key Facts
Cochlear Ltd, Major Products and Services
Cochlear Ltd Number of Pipeline Products by Development Stage
Cochlear Ltd Pipeline Products Summary by Development Stage
Cochlear Ltd Ongoing Clinical Trials by Trial Status
Cochlear Ltd Ongoing Clinical Trials Summary
Custom Sound Pro Fitting Software - Product Status
Custom Sound Pro Fitting Software - Product Description
Nucleus 7 Sound Processor For Nucleus 22 Implant - Product Status
Nucleus 7 Sound Processor For Nucleus 22 Implant - Product Description
Nucleus Kanso 2 Sound Processor - Product Status
Nucleus Kanso 2 Sound Processor - Product Description
Nucleus Profile Plus - Product Status
Nucleus Profile Plus - Product Description
Nucleus SmartNav System - Product Status
Nucleus SmartNav System - Product Description
OSIA 2 System - Product Status
OSIA 2 System - Product Description
OSIA 2 System - A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market
Cochlear Ltd, Key Employees
Cochlear Ltd, Key Employee Biographies
Cochlear Ltd, Other Locations
Cochlear Ltd, Subsidiaries
Glossary